High cure rates and reduced long-term toxicity in paediatric Hodgkin's disease: the German-Austrian multicenter trial DAL-HD-90. The German-Austrian Paediatric Hodgkin's Disease Study Group. - Schellong,G.; Pötter,R.; Brämswig,J. (J Clin Oncol, 1999)